Codes / ICD10CM / C11.9

C11.9 Malignant neoplasm of nasopharynx, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of nasopharynx, unspecified

Summary

Malignant neoplasm of the nasopharynx, unspecified, is a cancer originating in the nasopharynx, the upper part of the throat behind the nose. This condition involves abnormal cell growth in the tissues lining this area, which connects the nasal cavity to the pharynx. It may spread to nearby structures or distant sites if untreated.

Causes

The exact cause is not fully understood, but genetic mutations and environmental factors are believed to contribute. Infection with the Epstein-Barr virus (EBV) is a significant associated factor in many cases. Other potential contributors include dietary habits and exposure to certain substances.

Risk Factors

  • Infection with Epstein-Barr virus (EBV)
  • Family history of nasopharyngeal carcinoma
  • Consumption of preserved or salted foods
  • Exposure to wood dust or formaldehyde
  • Male gender
  • Age, particularly between 30 and 50

Symptoms

  • Nasal congestion or blockage
  • Nosebleeds
  • Hearing loss or ear pain
  • Swelling in the neck (lymph node enlargement)
  • Difficulty breathing or speaking
  • Unexplained weight loss

Diagnosis

Diagnosis begins with a physical examination and medical history review. Nasal endoscopy is typically performed to visualize the nasopharynx. Imaging tests such as MRI or CT scans assess the extent of the tumor. A biopsy of the nasopharyngeal tissue may be conducted to confirm malignancy.

Treatment Options

  • Radiation Therapy: Often first-line treatment, especially effective due to the location's sensitivity.
  • Chemotherapy: Used in conjunction with radiation or for more advanced stages.
  • Surgery: May be considered for localized tumors or to address complications.
  • Targeted Therapy: For cases with specific genetic markers.

Prognosis and Follow-Up

Prognosis depends on the stage at diagnosis, tumor size, and response to treatment. Regular follow-up appointments are essential to monitor for recurrence or metastasis. Long-term surveillance may include imaging and physical exams.

Complications

  • Metastasis to distant sites (e.g., bones, lungs)
  • Hearing loss or ear infections
  • Difficulty swallowing or speaking
  • Lymph node enlargement
  • Fatigue and weight loss

Lifestyle & Prevention

  • Avoid exposure to known carcinogens like wood dust or formaldehyde.
  • Maintain a balanced diet rich in fruits and vegetables.
  • Practice good hygiene to reduce infection risk.
  • Limit consumption of preserved or salted foods.

When to Seek Professional Help

Seek medical attention if symptoms such as persistent nasal congestion, unexplained weight loss, or neck swelling occur. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use C11.9 for cases where the malignant neoplasm of the nasopharynx is documented as unspecified. Ensure documentation supports the lack of further specification (e.g., no mention of superior, posterior, or lateral wall involvement). Verify that the diagnosis aligns with clinical findings to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C11.9 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.